Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network
Agency: Centers for Disease Control and Prevention - ERA
- 93.185 -- Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects
Forecasted opportunityLast Updated: Jul 28, 2026
Important dates
- Forecasted post date: October 30, 2026
- Forecasted application due date: December 31, 2026
- Forecasted award date: August 31, 2027
- Forecasted project start date: September 30, 2027
- Fiscal Year: 2027
Award details
- Expected project funding: $75,250,000
- Expected awards: 6
Award min.
$1,350,000
Award max.
$3,550,000
- Funding opportunity number:RFA-IP-27-026
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: July 28, 2026
- Archive date: January 30, 2027
- Version: 1
Summary
The purpose of this notice of funding opportunity (NOFO) is to continue the work of the US Influenza Vaccine Effectiveness (Flu VE) Network. Influenza and other respiratory pathogens are important causes of morbidity, mortality, and healthcare burden across the age spectrum. This network provides evidence needed to improve the effectiveness of influenza and other respiratory pathogen vaccines. You would propose work under this NOFO to include: 1) annual VE and correlates of protection surveillance from active enrollment and systematic respiratory pathogen testing of outpatients; 2) electronic acute respiratory illness and VE surveillance; 3) household transmission research studies; and 4) immunogenicity research studies.
This is a multi-component NOFO of Component A, B, C and D. The anticipated award number for each component is: five for Component A (VE and correlates of protection), one for Component B (Coordination and surge capacity), two for Component C (Household transmission studies) and three for Component D (Immunogenicity studies). You are required to apply for either Component A (VE and correlates of protection) or B (Coordination and surge capacity) but not both. If you apply for Component A, you may also apply for optional Components C (Household transmission studies) or D (Immunogenicity studies) or both. If you apply for Component B, you may also apply for optional Component D.
We expect to fund 5 sites for Component A up to $1,800,000 per site annually and 1 site for Component B up to $1,800,000 annually. Up to 2 sites selected for Component A may be awarded optional Component C to be funded up to $1,00,000 per site annually. Up to 3 sites selected for either Components A or B may be awarded optional Component D to be funded up to $750,000 per site annually.
Eligibility
Education
- Public and state institutions of higher education
- Independent school districts
- Private institutions of higher education
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
Government
- City or township governments
- County governments
- Special district governments
- Federally recognized Native American tribal governments
- State governments
- Public and Indian housing authorities
Business
- For-profit organizations other than small businesses
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: jpatterson@cdc.gov
jpatterson@cdc.gov
Link to additional information
No additional information is available
